AlphaGrep UK
AXSM icon

AlphaGrep UK’s Axsome Therapeutics AXSM Stock Holding History

AlphaGrep UK’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$488K Buy
2,649
+1,709
+182% +$372K 0.15% 256
2026
Q2 		$230K Sell
940
-1,104
-54% -$239K 0.07% 629
2026
Q1 		$345K Buy
2,044
+481
+31% +$83.1K 0.1% 442
2025
Q4 		$285K Buy
+1,563
New +$218K 0.1% 459

Other funds holding AXSM

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 42.55% 1-Year Est. Return
Alethea Capital Management
Alethea Capital Management Mercer Island, Washington $197M AUM 51.86% 1-Year Est. Return

AlphaGrep UK's AXSM Position: Q3 2026 in Review

AlphaGrep UK increased its Axsome Therapeutics (AXSM) stake by 182% in Q3 2026, buying an estimated $372K and bringing the position to 2,649 shares worth $488K. The position accounts for 0.15% of the portfolio, ranked #256.

AlphaGrep UK first reported a position in AXSM in Q4 2025 and has held it in 4 quarters since. 348 funds tracked by Wall St. Rank hold AXSM as of Q3 2026.

  • AlphaGrep UK held 2,649 shares of Axsome Therapeutics worth $488K as of Q3 2026.
  • AlphaGrep UK bought 1,709 Axsome Therapeutics shares in Q3 2026, an estimated $372K.
  • Axsome Therapeutics made up 0.15% of AlphaGrep UK's portfolio in Q3 2026, its #256 holding.
  • AlphaGrep UK first reported a position in Axsome Therapeutics in Q4 2025 and has held it in 4 quarters since.
  • 348 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q3 2026.

Based on AlphaGrep UK's 13F filing for Q3 2026, filed 12 Nov 2026.